Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes

BMC CANCER

Olbertova, H; Plevova, K; Pavlova, S; Malcikova, J; Kotaskova, J; Stranska, K; Spunarova, M; Trbusek, M; Navrkalova, V; Dvorackova, B; Tom, N; Pal, K; Jarosova, M; Brychtova, Y; Panovska, A; Doubek, M; Pospisilova, S, 2022: Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes. BMC CANCER 22(1), doi: 10.1186/s12885-022-09221-z

Research Groups:

Medical Genomics
Genomics Core Facility

CEITEC authors:

Jana Kotašková, Ph.D.
Kamila Stránská, Ph.D.
Veronika Navrkalová, Ph.D.
Prof. Michael Doubek, Ph.D.
Jitka Malčíková, Ph.D.
Prof. Šárka Pospíšilová, Ph.D.
Šárka Pavlová, Ph.D.